GSEA based on the cancer hallmark gene sets revealed significant inhibition of MYC targets, E2F targets, G2M checkpoint, and mTORC1 signaling pathways in AZ628-treated IOMM-Lee cells (Fig. 7A). This evidence concerns the gene MYC and cancer.